Abstract:Protein nanocages are highly ordered nanometer scale architectures, which are typically formed by homo- or hetero-self-assembly of multiple monomers into symmetric structures of different size and shape. The intrinsic characteristics of protein nanocages make them very attractive and promising as a biological nanomaterial. These include, among others, a high surface/volume ratio, multi-functionality, ease to modify or manipulate genetically or chemically, high stability, mono-dispersity, and biocompatibility. Since the beginning of the investigation into protein nanocages, several applications were conceived in a variety of areas such as drug delivery, vaccine development, bioimaging, biomineralization, nanomaterial synthesis and biocatalysis. The ability to generate large amounts of pure and well-folded protein assemblies is one of the keys to transform nanocages into clinically valuable products and move biomedical applications forward. This calls for the development of more efficient biomanufacturing processes and for the setting up of analytical techniques adequate for the quality control and characterization of the biological function and structure of nanocages. This review concisely covers and overviews the progress made since the emergence of protein nanocages as a new, next-generation class of biologics. A brief outline of non-viral protein nanocages is followed by a presentation of their main applications in the areas of bioengineering, biotechnology, and biomedicine. Afterwards, we focus on a description of the current processes used in the manufacturing of protein nanocages with particular emphasis on the most relevant aspects of production and purification. The state-of-the-art on current characterization techniques is then described and future alternative or complementary approaches in development are also discussed. Finally, a critical analysis of the limitations and drawbacks of the current manufacturing strategies is presented, alongside with the identification of the major challenges and bottlenecks.

Protein nanocage architectures for the delivery of therapeutic proteins

Assembly of Protein Cages for Drug Delivery

Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s.

Nanocarriers for intracellular delivery of proteins in biomedical applications: strategies and recent advances

Emerging prospects of protein/peptide-based nanoassemblies for drug delivery and vaccine development

Manufacturing of non-viral protein nanocages for biotechnological and biomedical applications

Tailoring nanocarriers for intracellular protein delivery.

Synthetic Nanocarriers for Intracellular Protein Delivery

An interaction network approach predicts protein cage architectures in bionanotechnology

Protein Nanoparticles: Promising Platforms for Drug Delivery Applications

A Versatile Ph-Responsive Platform for Intracellular Protein Delivery Using Calcium Phosphate Nanoparticles.

Efficient Delivery of Cytosolic Proteins by Protein-Hexahistidine-Metal Co-Assemblies

Redesign of protein nanocages: the way from 0D, 1D, 2D to 3D assembly

Bioengineering Strategies for Protein-Based Nanoparticles

Recent Updates on Diverse Nanoparticles and Nanostructures in Therapeutic and Diagnostic Applications with Special Focus on Smart Protein Nanoparticles: A Review

Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins.

Simple and Efficient Targeted Intracellular Protein Delivery with Self‐Assembled Nanovehicles for Effective Cancer Therapy

Engineered protein nanodrug as an emerging therapeutic tool

Design and structure of two new protein cages illustrate successes and ongoing challenges in protein engineering

Nanomaterial Strategies for Delivery of Therapeutic Cargoes

Developing Porous Protein Cage Nanoparticles as Cargo-Loadable and Ligand-Displayable Modular Delivery Nanoplatforms